Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1183 of 5804
-
Virtual rehab hub aims to cut surgery complications for colorectal cancer patients
Disease control Recruiting nowObjectives: The primary aim of this project is to establish the effectiveness of an individualised stepped, multidisciplinary intervention, including education and peer support group, delivered via a virtual multimodal (p)rehabilitation hub, in reducing postoperative complicatio…
Phase: NA • Sponsor: Surgical Outcomes Research Centre (SOuRCe) • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can community action and cash help end violence against women? malawi trial aims to find out
Prevention Recruiting nowViolence against women is complex and must be addressed at multiple levels, with leadership from women themselves on how to bring about positive change to free women and girls from daily experiences of violence and to promote their rights. It is in this context that the Pamodzi K…
Phase: NA • Sponsor: George Washington University • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Could a lower dose of this thyroid cancer drug be just as good?
Disease control Recruiting nowThis open-label, randomized phase II trial evaluates the dose delivery, tolerance, and efficacy of two dosing regimens of lenvatinib among patients with radioactive iodine resistant (RAIR) differentiated thyroid cancer (DTC).
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Engineered immune cells take on autoimmune diseases in early trial
Disease control Recruiting nowThis is a prospective, single-arm, open-label and dose-escalation Investigator Initialed study to evaluate LUCAR-DKS1 in adult subjects with relapsed/refractory autoimmune diseases.
Phase: EARLY_PHASE1 • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New blood test could spot deadly lung clots faster
Diagnosis Not yet recruitingIn response to the high mortality rate of patients with acute pulmonary embolism (APE) and the fact that only a small proportion of deceased patients can receive correct diagnosis, this study will use a sensitive, non-invasive, and feasible new thrombus molecular marker (TAT/PIC/…
Sponsor: Beijing Anzhen Hospital • Aim: Diagnosis
Last updated Jun 26, 2026 18:36 UTC
-
Vaping cessation pill under trial: varenicline tested on 326 adults
Disease control Recruiting nowThis is randomized, placebo-controlled clinical trial in treatment-seeking adults who report regular e-cigarette use to test the hypothesis that varenicline is efficacious for quitting e-cigarettes.
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Double radiation attack may slow tough gut tumors
Disease control Recruiting nowThis phase I trial tests the safety and effectiveness of stereotactic body radiation therapy (SBRT) followed by 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in treating patients with large well-differentiated grade 1-2 digestive system neuroendocrine tumors that ca…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
SEAL brain health under scrutiny: new study aims to detect hidden blast injuries
Knowledge-focused Recruiting nowThis is a 4-year, longitudinal study of 100 active-duty Navy SEALs. The goal of the study is to determine whether repeated blast exposure affects SEAL brain health and to develop an initial diagnostic testing protocol that detects repeated blast brain injury.
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
New insulin method aims to protect kidneys in diabetes patients
Disease control Recruiting nowThe purpose of this research is to evaluate outcomes of physiologic insulin re-sensitization (PIR) in patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM).
Phase: NA • Sponsor: Well Cell Global • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Electric field device takes on pancreatic cancer in new trial
Disease control Recruiting nowThe purpose of this clinical trial is to assess the safety and tolerability of TTFields in combination with chemotherapy in adults with metastatic pancreatic adenocarcinoma based on treatment-emergent adverse events of chemotherapy (modFOLFIRINOX) or device (TTFields). The main …
Phase: PHASE1, PHASE2 • Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Bird flu vaccine study: does timing matter?
⭐️ VACCINE ⭐️ OngoingGiven the recent circulation of avian influenza A(H5N1) clade 2.3.4.4b strains in birds and mammals in North America, Canada procured a supply of Arepanrix™ H5N1 for potential use in persons at high risk of highly pathogenic avian influenza exposure. This vaccine received regula…
Phase: PHASE4 • Sponsor: Canadian Immunization Research Network • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:11 UTC
-
New peptide drug hopes to boost brain repair after stroke
Disease control Recruiting nowThis is a randomized, double-blinded, placebo-controlled study investigating the safety and efficacy of QD202 injection in patients with acute ischemic stroke undergoing thrombolysis excluding endovascular thrombectomy. Up to 120 male and female patients with acute ischemic strok…
Phase: PHASE2 • Sponsor: Shanghai QuietD Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Supercharged baby formula may boost brain growth in Heart-Disease infants
Disease control Recruiting nowThe purpose of this study is to compare the effect of high and ordinary energy density enteral nutrition for improving physical growth and brain cognitive development in infants with congenital heart disease after operation, as well as evaluate the safety of interventions.
Phase: NA • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New inhaled TB drug shows promise in early trial
Disease control Recruiting nowA Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of Nebulised RESP30TB in Adults with Newly Diagnosed, Rifampicin Susceptible Pulmonary Tuberculosis
Phase: PHASE2 • Sponsor: Thirty Respiratory Limited • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Pharmacists step in to tackle diabetes crisis
Disease control Recruiting nowAs of 2024, nine percent of Albertans are living with Type 2 diabetes, which increases their risk for cardiovascular disease, stroke, blindness, and kidney failure. Unfortunately, less than half of patients have controlled Type 2 diabetes. We are well aware of the factors which l…
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New group therapy aims to rewire depressed brains
Symptom relief Recruiting nowMajor depressive disorder (MDD) is one of the most common psychiatric conditions and often remains difficult to treat effectively. Many patients continue to experience residual symptoms or relapse even after receiving established forms of psychotherapy. This study tests whether t…
Phase: NA • Sponsor: Philipps University Marburg • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Stress relief for refugee families: a new hope for mothers and kids
Symptom relief OngoingThis study evaluates whether the group-based mental health program Self-Help Plus (SH+) can improve the mental health, wellbeing, and functioning of refugee mothers and their preschool-aged children living in Rhino Refugee Settlement (Rhino Camp), Uganda. SH+ is a stress manageme…
Phase: NA • Sponsor: Uppsala University • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New Single-Dose flu drug shows promise in kids trial
Disease control CompletedThe goal of this phase III study is to learn if ZX-7101A for oral suspension works to treat uncomplicated influenza in Pediatric Participants aged 2 to 11 years. The main question it aims to answer is: What medical problems do participants have when taking drug ZX-7101A for oral…
Phase: PHASE3 • Sponsor: Nanjing Zenshine Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New flu vaccine trial aims to protect moms and babies
⭐️ VACCINE ⭐️ Recruiting nowThis is a randomized, double-blind, positive controlled phase Ⅲ clinical trial to assess the immunogenicity and safety of Sinovac QIV in pregnant women. A total of 150 healthy pregnant women aged 18\~39 years at 20 to 32 weeks of pregnancy will be enrolled. All participants will …
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:00 UTC
-
One-hour talk before c-section may stop postpartum anxiety and trauma
Prevention Recruiting nowPerinatal mental health disorders are the most prevalent perinatal comorbidity and are associated with the primary cause of maternal mortality in the United States (US) - suicide. Diagnosis of a high-risk pregnancy and cesarean delivery (CD) are both associated with increased ris…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC